Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome

MLA

Shulan Zhang, et al. “Antibodies to Phosphatidylserine/Prothrombin (APS/PT) Enhanced the Diagnostic Performance in Chinese Patients with Antiphospholipid Syndrome.” Clinical Chemistry and Laboratory Medicine (CCLM), vol. 56, Mar. 2018, pp. 939–46. EBSCOhost, https://doi.org/10.1515/cclm-2017-0811.

APA

Shulan Zhang, Yongzhe Li, Xiaofeng Zeng, Ziyan Wu, Fengchun Zhang, Jiuliang Zhao, Gary L Norman, & Wen Zhang. (2018). Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome. Clinical Chemistry and Laboratory Medicine (CCLM), 56, 939–946. https://doi.org/10.1515/cclm-2017-0811

Chicago

Shulan Zhang, Yongzhe Li, Xiaofeng Zeng, Ziyan Wu, Fengchun Zhang, Jiuliang Zhao, Gary L Norman, and Wen Zhang. 2018. “Antibodies to Phosphatidylserine/Prothrombin (APS/PT) Enhanced the Diagnostic Performance in Chinese Patients with Antiphospholipid Syndrome.” Clinical Chemistry and Laboratory Medicine (CCLM) 56 (March): 939–46. doi:10.1515/cclm-2017-0811.